ElectromedELMD
About: Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
Employees: 174
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
217% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 6
139% more call options, than puts
Call options by funds: $575K | Put options by funds: $241K
24% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 29
16% more funds holding
Funds holding: 82 [Q4 2024] → 95 (+13) [Q1 2025]
5.73% more ownership
Funds ownership: 37.63% [Q4 2024] → 43.36% (+5.73%) [Q1 2025]
6% less capital invested
Capital invested by funds: $94.1M [Q4 2024] → $88.5M (-$5.59M) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for ELMD.
Financial journalist opinion
Based on 3 articles about ELMD published over the past 30 days









